New CSF biomarkers on the block
A growing number of cerebrospinal fluid biomarkers are now available to capture different aspects of Alzheimer's disease. People are increasingly aware that these biomarkers represent a real‐time reflection of pathological mechanisms that are ongoing in the brain. These novel markers can be added to the panel of existing ones like amyloid beta, total Tau and phosphoTau that are currently used for sensitive diagnosis of Alzheimer's disease, either alone or in combination.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
New CSF biomarkers on the block ; volume:8 ; number:10 ; year:2016 ; pages:1118-1119 ; extent:2
EMBO molecular medicine / European Molecular Biology Organization ; 8, Heft 10 (2016), 1118-1119 (gesamt 2)
- Creator
- DOI
-
10.15252/emmm.201606801
- URN
-
urn:nbn:de:101:1-2022111007205531604844
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Teunissen, Charlotte E.
- Parnetti, Lucilla
Other Objects (12)
Diurnal oscillation of CSF Aβ and other AD biomarkers
CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Blood and CSF biomarkers for post-stroke epilepsy: a systematic review
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Diurnal oscillation of CSF Aβ and other AD biomarkers
CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Blood and CSF biomarkers for post-stroke epilepsy: a systematic review
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Diurnal oscillation of CSF Aβ and other AD biomarkers
CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Blood and CSF biomarkers for post-stroke epilepsy: a systematic review
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition